Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia Gravis Market | DelveInsight
Published on 08/07/2025 at 18:06 | prnewswire.co.uk+14699457679
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/johnson--johnsons-imaavy-gets-fda-approval-taking-on-top-players-in-myasthenia-gravis-market--delveinsight-302462819.html
en | boerse | 67956768 |
